Agape ATP (ATPC) Net Income towards Common Stockholders (2017 - 2026)
Agape ATP's (ATPC) quarterly Net Income towards Common Stockholders came in at $149437.0 in Q2 2026, up 123.98% year-over-year from $66719.7 in Q2 2025, and up 139.94% quarter-over-quarter from -$374124.0 in Q1 2026.
Powered by 
Analysis
Agape ATP (ATPC) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends
Agape ATP (ATPC) has reported Net Income towards Common Stockholders for 10 consecutive years, with $149437.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 123.98% year-over-year to $149437.0 in Q2 2026; TTM through Jun 2026 was -$1.2 million, a 56.36% increase from a year earlier, with the FY2025 full-year figure at -$2.3 million, up 6.11% from the prior year.
- Net Income towards Common Stockholders was $149437.0 for Q2 2026 at Agape ATP, up from -$374124.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $149437.0 in Q2 2026 and troughed at -$965359.0 in Q4 2023.
- A 5-year average of -$484147.7 and a median of -$433195.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders plunged 61.98% in 2024 and jumped 123.98% in 2026, its largest moves.
- Over 5 years, Net Income towards Common Stockholders stood at -$723072.0 in 2022, then tumbled by 33.51% to -$965359.0 in 2023, then climbed by 21.57% to -$757101.0 in 2024, then soared by 55.45% to -$337265.0 in 2025, then surged by 144.31% to $149437.0 in 2026.
- The last three Net Income towards Common Stockholders figures came in at $149437.0 (Q2 2026), -$374124.0 (Q1 2026), and -$337265.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 719.00 Mn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 456.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 295.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 118.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 74.40 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -26.50 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 13.70 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Agape ATP | 2.38 Mn | 2.38 Mn | - | 149,437.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149,437.00 |
| Mar 31, 2026 | -374,124.00 |
| Dec 31, 2025 | -337,265.00 |
| Sep 30, 2025 | -595,370.00 |
| Jun 30, 2025 | -623,246.00 |
| Mar 31, 2025 | -747,844.00 |
| Dec 31, 2024 | -757,101.00 |
| Sep 30, 2024 | -524,039.00 |
| Jun 30, 2024 | -432,315.00 |
| Mar 31, 2024 | -703,094.00 |
| Dec 31, 2023 | -965,359.00 |
| Sep 30, 2023 | -324,735.00 |
| Jun 30, 2023 | -379,449.00 |
| Mar 31, 2023 | -434,075.00 |
| Dec 31, 2022 | -723,072.00 |
| Sep 30, 2022 | -240,217.00 |
| Jun 30, 2022 | -404,344.00 |
| Mar 31, 2022 | -298,446.00 |
| Dec 31, 2021 | -977,540.00 |
| Sep 30, 2021 | -571,265.00 |